We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
US-based biotechnology firm Amgen has entered into a partnership with Adaptive Biotechnologies to develop a therapeutic that could prevent or treat COVID-19 (coronavirus) disease. Amgen and Adaptive have
Roche has entered into a partnership with the US Food & Drug Administration (FDA) to commence a phase III clinical trial of Actemra/RoActemra (tocilizumab) in hospitalised patients with
The US Food and Drug Administration (FDA) has approved Gilead Sciences’ supplemental application for sofosbuvir and velpatasvir (Epclusa) to treat hepatitis C virus (HCV) in children aged 6
Canada-based healthcare biotechnology firm Entos Pharmaceuticals has announced their development of a DNA vaccine for the COVID-19 (coronavirus) pandemic using its Fusogenix nanomedicine platform. Entos’ proprietary drug delivery
The Critical Path Institute (C-Path) and H. Lundbeck A/S (Lundbeck) have announced a data-sharing collaboration to provide advanced drug development tools in Alzheimer’s disease (AD). Established in 2005,
US-based pharmaceutical company Pfizer has joined forces with German biotechnology firm BioNTech to co-develop a potential vaccine for the COVID-19 (coronavirus) pandemic. The companies will jointly develop BioNTech’s
Merck has announced top-line results from Phase 3 trials (COUGH-1 and COUGH-2) evaluating gefapixant, an investigational treatment for refractory or unexplained chronic cough (a cough lasting more than
Medical technology firm Hologic’s molecular diagnostic test has received an emergency use authorisation approval from the US Food and Drug Administration (FDA) for the detection of SARS-CoV-2 virus,
Eli Lilly and Incyte have received breakthrough therapy designation from the US Food and Drug Administration (FDA) for baricitinib to treat alopecia areata (AA). Alopecia areata is an
UK-based biotechnology firm Redx Pharma has announced that it will accept a cash offer from American investment group Redmile for the takeover of the company. The decision comes